Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Perhaps now the TO THE MOON posters

Re: Milestone....ronran

in response to by
posted on Apr 05, 2010 05:21PM

We both know that the BoD have no control over licensing, so the onus remains with Alliacense to react to any '336 update.

Why does the fact that there is no consistent revenue stream for which to predict future revenues never enter into the berate-the-BoD-for-everything farrago?

If the BoD can't know or predict from month-to-month what revenues to expect, how can one seriously expect the investment community to do other than let the price stagnate?

Changing the incumbent BoD will do absolutely nothing for the share price without the benefit of a predictable revenue, not now, not then, nor in the future. I humbly suggest that it was, in the main, the expectation of a constant flow of revenues which drove the price above $2, on all sides.

What followed is history, not incompetence.

By all means, please take it as a given that all my posts conclude with "BRING IT ON" without my need to repeat it.

.

.

.

Be well

Share
New Message
Please login to post a reply